MDS' Q2 Revenues Drop 21 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – MDS today reported that its second-quarter revenues fell 21 percent and it swung to a loss from a profit year over year as soft spending markets took a toll on its top and bottom lines.

The Toronto-based firm brought in total revenues of $282 million for the three-month period ended April 30, compared to revenues of $350 million for the second quarter of 2008. It said that excluding the impact of foreign exchange, acquisitions, and divestitures its net revenue decreased 10 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.